Mostra el registre d'ítem simple

dc.contributor.authorBayó-Puxan, Núria
dc.contributor.authorRodríguez-Mias, Ricard
dc.contributor.authorGoldflam, Michael
dc.contributor.authorKotev, Martin
dc.contributor.authorCiudad, Sonia
dc.contributor.authorHipolito, Christopher J.
dc.contributor.authorVarese, Monica
dc.contributor.authorSuga, Hiroaki
dc.contributor.authorCampos-Olivas, Ramón
dc.contributor.authorBarril, Xavier
dc.contributor.authorGuallar, Víctor
dc.contributor.authorTeixidó, Meritxell
dc.contributor.authorGarcía, Jesús
dc.contributor.authorGiralt, Ernest
dc.contributor.otherBarcelona Supercomputing Center
dc.date.accessioned2016-03-15T11:11:29Z
dc.date.available2016-03-15T11:11:29Z
dc.date.issued2015-11-10
dc.identifier.citationBayó-Puxan, Núria [et al.]. Combined Use of Oligopeptides, Fragment Libraries, and Natural Compounds: A Comprehensive Approach To Sample the Druggability of Vascular Endothelial Growth Factor. "ChemMedChem", 10 Novembre 2015.
dc.identifier.issn1860-7187
dc.identifier.urihttp://hdl.handle.net/2117/84365
dc.description.abstractThe modulation of protein–protein interactions (PPIs) is emerging as a highly promising tool to fight diseases. However, whereas an increasing number of compounds are able to disrupt peptide-mediated PPIs efficiently, the inhibition of domain–domain PPIs appears to be much more challenging. Herein, we report our results related to the interaction between vascular endothelial growth factor (VEGF) and its receptor (VEGFR). The VEGF–VEGFR interaction is a typical domain–domain PPI that is highly relevant for the treatment of cancer and some retinopathies. Our final goal was to identify ligands able to bind VEGF at the region used by the growth factor to interact with its receptor. We undertook an extensive study, combining a variety of experimental approaches, including NMR-spectroscopy-based screening of small organic fragments, peptide libraries, and medicinal plant extracts. The key feature of the successful ligands that emerged from this study was their capacity to expose hydrophobic functional groups able to interact with the hydrophobic hot spots at the interacting VEGF surface patch.
dc.description.sponsorshipThis work was supported by the Ministry of Economy and Competitiveness and the European Fund for Regional Development (MINECO-FEDER) (Bio2013-40716-R) and the Generalitat de Catalunya (XRB and 2014-SGR-521). We also thank the NMR facility at the Scientific and Technological Centre of the University of Barcelona (CCiT UB) for their technical support.
dc.format.extent13 p.
dc.language.isoeng
dc.publisherWiley Online Library
dc.rightsAttribution-NonCommercial-NoDerivs 4.0 Spain
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/es/
dc.subjectÀrees temàtiques de la UPC::Enginyeria mecànica::Impacte ambiental
dc.subject.lcshProtein drugs
dc.subject.otherDrug discovery
dc.subject.otherFragment screening
dc.subject.otherGrowth factors
dc.subject.otherPeptides
dc.subject.otherProtein–protein interactions
dc.titleCombined Use of Oligopeptides, Fragment Libraries, and Natural Compounds: A Comprehensive Approach To Sample the Druggability of Vascular Endothelial Growth Factor
dc.typeArticle
dc.subject.lemacProteïnes
dc.identifier.doi10.1002/cmdc.201500467
dc.description.peerreviewedPeer Reviewed
dc.relation.publisherversionhttp://onlinelibrary.wiley.com/doi/10.1002/cmdc.201500467/abstract
dc.rights.accessOpen Access
dc.description.versionPostprint (published version)
dc.relation.projectidinfo:eu-repo/grantAgreement/MINECO//BIO2013-40716-R/ES/PEPTIDOS COMO AGENTES TERAPEUTICOS: MODULACION DE INTERACCIONES PROTEINA-PROTEINA Y TRANSPORTE AL CEREBRO/
local.citation.publicationNameChemMedChem


Fitxers d'aquest items

Thumbnail

Aquest ítem apareix a les col·leccions següents

Mostra el registre d'ítem simple